BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7492927)

  • 1. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
    Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
    Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
    McCormick SU
    J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
    Friedman M; Venkatesan TK; Caldarelli DD
    Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
    Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Turiansky G; Wagner KF
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Kaposi's lesions in the HIV-infected patient.
    Nichols CM; Flaitz CM; Hicks MJ
    J Am Dent Assoc; 1993 Nov; 124(11):78-84. PubMed ID: 8227776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
    Epstein JB
    Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
    Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
    J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities for intraoral Kaposi's sarcoma: report of case.
    Chockley B; Coke JM
    Spec Care Dentist; 1991; 11(6):231-3. PubMed ID: 1839938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
    Moyle G; Youle M; Barton S
    Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Off-label use of vincristine for intralesional treatment of isolated papules in Kaposi's sarcoma: Dermatologic experience with 10 patients].
    Peduto T; Fabbrocini G; Delfino M; Nappa P; Guarino M; Cillo F
    Ann Dermatol Venereol; 2020 Feb; 147(2):140-143. PubMed ID: 31810583
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intralesional vinblastine in the treatment of Kaposi's sarcoma. Presentation of a case].
    Gaglioti D; Ficarra G; Nardi P
    Minerva Stomatol; 1989 Sep; 38(9):955-7. PubMed ID: 2811811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caution in the use of local therapies for Kaposi's sarcoma.
    Tappero JW; Berger TG
    Arch Dermatol; 1993 Jan; 129(1):42. PubMed ID: 8420484
    [No Abstract]   [Full Text] [Related]  

  • 17. Local treatment of AIDS-associated bulky Kaposi's sarcoma in the head and neck region.
    Shimomura S; Kikuchi Y; Oka S; Ishitoya J
    Auris Nasus Larynx; 2000 Oct; 27(4):335-8. PubMed ID: 10996492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
    Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-TerĂ¡n G
    Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
    Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
    N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.